top of page
  • _

Peregrine Pharmaceuticals - NEW EBOLA Antiviral Therapy

Peregrine Pharmaceuticals of Tustin , California , USA - is publishing very promising DATA on Phosphatidylserine-targeting monoclonal Antibody- Bravituximab for treatment of EBOLA- Viral Hemorrhagic Fever. It has already been used SAFELY in oncologic therapy in 600 patients - Worldwide

1 view0 comments

Recent Posts

See All

New Robot Sampling

copy and paste in your browser:


bottom of page